GE HealthCare Technologies shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a bullish case for the company’s diagnostic imaging business.
The new facility will enable production of 25 million more patient doses per year of contrast media by the end of 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback